Shanghai Institute of Materia Medica Chinese Academy of Sciences:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9316
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that provides research and development of traditional Chinese medicine. The institute offers solutions in the areas of drug discovery and drug development. It also offers studies of structure-activity relationships of bioactive substances, new chemical entities, pre-clinical evaluation and pharmaceutical development. SIMM develops drugs such as artemether, dimercaptosuccinic acid, and huperzine a, depsides salts, antofloxacin hydrochloride, and others. The institute carries out research in the areas of drug screening, pharmacology, medicinal chemistry, products chemistry, combinatorial chemistry, toxicology, pharmacokinetics and computer-aided drug design, among others. SIMM is headquartered in Pudong, China.

Shanghai Institute of Materia Medica Chinese Academy of Sciences – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12
Licensing Agreements 13
Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13
Asset Transactions 14
3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Key Competitors 16
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Key Employees 17
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Government and Public Interest 19
Jun 22, 2018: Scientists Make a Major Breakthrough in Signal Transduction of GPCR 19
Product News 20
Aug 30, 2018: Biomimetic strategy realizes imaging-guided treatment of Breast Cancer Metastasis 20
Jan 03, 2018: Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Key Facts 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12
Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13
3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Competitors 16
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Employees 17

List of Figures
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Shanghai Institute of Materia Medica Chinese Academy of Sciences:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invuity Inc (IVTY):企業の財務・戦略的SWOT分析
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • Worldpay Group Ltd:企業の戦略・SWOT・財務分析
    Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nippon Seiro Co., Ltd. (5010):企業の財務・戦略的SWOT分析
    Nippon Seiro Co., Ltd. (5010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SRI International-医療機器分野:企業M&A・提携分析
    Summary SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economi …
  • Mirabilis Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Mirabilis Medical Inc (Mirabilis Medical) is a healthcare equipment company that develops a non-invasive therapeutic ultrasound platform for the treatment of uterine fibroids in women. The company offers platform that targets symptoms of uterine fibroids such as pain, abnormal bleeding, preg …
  • Clinical Ink Inc:医療機器:M&Aディール及び事業提携情報
    Summary Clinical Ink Inc (Clinical Ink) is a technology company that offers eSource and patient engagement solutions. The company offers data management solution, monitoring solution, clinical site solution and patient centric solution. It offers SureSource, an eSource platform to capture eSource da …
  • Al Jaber Group:企業の戦略・SWOT・財務分析
    Al Jaber Group - Strategy, SWOT and Corporate Finance Report Summary Al Jaber Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • First Midwest Bancorp, Inc.:企業の戦略・SWOT・財務情報
    First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ABB, Ltd.:企業の戦略・SWOT・財務情報
    ABB, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ABB, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Pepticom Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pepticom Ltd (Pepticom) is a drug discovery and development company focused on novel peptide drug candidates. The company's artificial intelligence platform for peptide design models based on the target's solved crystal structure of the target protein. Its products includes copaxone, used fo …
  • Sinopec Oilfield Service Corp (600871):企業の財務・戦略的SWOT分析
    Sinopec Oilfield Service Corp (600871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Reliance Anil Dhirubhai Ambani Group:企業の戦略的SWOT分析
    Reliance Anil Dhirubhai Ambani Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Codan Radio Communications:企業の戦略・SWOT・財務情報
    Codan Radio Communications - Strategy, SWOT and Corporate Finance Report Summary Codan Radio Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務分析
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Novelion Therapeutics Inc (NVLN):企業の財務・戦略的SWOT分析
    Novelion Therapeutics Inc (NVLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Clark Enterprises Inc:企業の戦略・SWOT・財務情報
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Abengoa, S.A.:企業の戦略・SWOT・財務情報
    Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report Summary Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SVOGL Oil Gas and Energy Ltd:企業の戦略的SWOT分析
    SVOGL Oil Gas and Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Corus Entertainment Inc. (CJR.B):企業の財務・戦略的SWOT分析
    Corus Entertainment Inc. (CJR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Amdocs Ltd (DOX):企業の財務・戦略的SWOT分析
    Amdocs Ltd (DOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆